Data / Form D filings / TRANSGENRX INC
TRANSGENRX INC: Form D filings
TRANSGENRX INC, a biotechnology company in Baton Rouge, LA, filed 3 Form D notices with the SEC between 2010 and 2011. The latest, on September 9, 2011, reports $6.5 million sold of a $15 million offering to 42 investors.
Find out what TRANSGENRX INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 340 EAST PARKER BLVD, Baton Rouge, LA, 70803
- Phone
- (888) 432-0721
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1274562
The full lists. Form D filings in Louisiana: 144 rows, $7.20, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 9, 2011 | Amendment | $15,000,000 | $6,505,600 | $8,494,400 | 42 | Oct 14, 2010 | sec.gov |
| Sep 28, 2010 | New notice | $10,000,000 | $0 | $10,000,000 | 0 | Yet to occur | sec.gov |
| Aug 4, 2010 | New notice | Indefinite | $420,000 | Indefinite | 4 | Jul 20, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Richard C. Cooper | Executive Officer, Director | |
| William C. Fioretti | Executive Officer, Director | |
| Robert B. Kenney | Director | |
| John B. Gallagher | Executive Officer, Director |
Other biotechnology companies in Louisiana that filed recently
- 28bio, Inc. $8.5 million · Oct 29, 2026
- Therapeutic Neuromodulation Systems LLC $1.7 million · Sep 21, 2026
Every Form D from the week of Sep 5, 2011 · All recent filings in Louisiana · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what TRANSGENRX INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.